Zdrowie i gospodarka · 24/12/1997

FDA Publishes Guidance on Residual Solvents in Pharmaceuticals

The FDA has released a new guidance document, Q3C Impurities: Residual Solvents, under the ICH framework, outlining acceptable levels of residual solvents in pharmaceuticals to ensure patient safety and recommending the use of less toxic solvents in manufacturing.